Sr. Director, Global New Product Planning: Cardiovascular Gene Editing

Lilly•Indianapolis, IN
•$166,500 - $244,200

About The Position

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Director, Global New Product Planning to shape clinical development and commercial strategy for its cardiovascular gene editing portfolio. New Product Planning bridges the research organization and customers, with the aim of delivering meaningful patient experiences while addressing the needs of physicians and payers. The role calls for an innovative thinker willing to challenge existing healthcare norms and treatment paradigms. It will help address questions related to target product profiles for single-course medicines, evidence needs for patients, physicians, regulators, and payers, valuation of one-time therapies against lifelong treatment, and the possibility of shifting care toward early prevention. This high-visibility role collaborates across research, development, and marketing and delivers strategic insights to leadership in Lilly’s Cardiometabolic Health group. The ideal candidate excels in a fast-paced, dynamic environment and has strong communication skills and attention to detail.

Requirements

  • Bachelor’s degree.
  • At least 5 years of experience in the pharmaceutical or biotechnology industry in new product planning, commercial strategy, or strategy consulting serving those functions.

Nice To Haves

  • Advanced degree (MBA, PhD, PharmD, or MS).
  • Degree in life sciences.
  • Experience in cardiovascular disease, lipid management, and/or genetic medicines.
  • Comfort with scientific data and ability to translate technical insights into commercial implications.
  • Experience with forecasting and risk-adjusted valuation.
  • Ability to advance work streams quickly in the face of ambiguity.
  • Deep scientific curiosity.
  • Proven ability to challenge conventional wisdom at all levels and produce innovative, patient-oriented solutions.
  • Clear written and spoken communication for scientific and non-scientific audiences.

Responsibilities

  • Develop expertise in cardiovascular and gene editing market landscapes, monitor relevant competitors, understand patient, physician, and payer needs, and share findings with Cardiometabolic Health leadership and business partners.
  • Own and evolve asset profiles, value propositions, and other commercial materials for the ASCVD gene editing portfolio as data become available, ensuring they reflect customer insights and support commercial success beyond registration.
  • Partner with market research colleagues to design and conduct research that informs clinical development strategy and commercial planning.
  • Partner with discovery, early-phase, and late-phase colleagues to shape development plans across the ASCVD gene editing portfolio and provide commercial input on study design and evidence needs.
  • Engage key regions and global affiliates to develop a global view of market landscapes and customer needs.
  • Lead commercial deliverables at each development milestone, including forecasts, risk-adjusted valuations, and investment recommendations for governance.

Benefits

  • Company bonus eligibility, depending in part on company and individual performance.
  • Eligibility to participate in a company-sponsored 401(k).
  • Pension.
  • Vacation benefits.
  • Eligibility for medical, dental, vision, and prescription drug benefits.
  • Flexible benefits, including healthcare and/or dependent day care flexible spending accounts.
  • Life insurance and death benefits.
  • Certain time off and leave of absence benefits.
  • Well-being benefits, including an employee assistance program, fitness benefits, and employee clubs and activities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service